Response to "What is the Current Clinical Impact of the CYP2C:TG Haplotype?"

被引：0
|
作者：
Zubiaur, Pablo [1 ]
Leeder, J. Steven [2 ,3 ]
Abad-Santos, Francisco [1 ,4 ]
Gaedigk, Andrea [2 ,3 ]
机构：
[1] Univ Autonoma Madrid UAM, Inst Invest Sanitaria Princesa IP, Inst Teofilo Hernando, Clin Pharmacol Dept,Hosp Univ La Princesa, Madrid, Spain
[2] Childrens Mercy Res Inst CMRI, Div Clin Pharmacol Toxicol & Therapeut Innovat, Kansas City, MO 64108 USA
[3] Univ Missouri Kansas City, Sch Med, Kansas City, MO 64110 USA
[4] Inst Salud Carlos III, Ctr Invest Biomed Red Enfermedades Hepat & Digest, Madrid, Spain
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2024年 / 115卷 / 02期
关键词：
D O I：
10.1002/cpt.3093
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：184 / 184
页数：1
相关论文
共 50 条
  • [1] Clopidogrel metabolism is not affected by the CYP2C:TG haplotype
    Coenen, Marieke
    Struik, Misha
    Wijnen, Petal
    Olie, Renske
    Bekers, Otto
    van Schaik, Ron
    Henskens, Yvonne
    PHARMACOGENETICS AND GENOMICS, 2025, 35 (01): : 18 - 18
  • [2] Impact of CYP2C:TG Haplotype on CYP2C19 Substrates Clearance In Vivo, Protein Content, and In Vitro Activity
    Zubiaur, Pablo
    Soria-Chacartegui, Paula
    Boone, Erin C. C.
    Prasad, Bhagwat
    Dinh, Jean
    Wang, Wendy Y. Y.
    Zugbi, Santiago
    Rodriguez-Lopez, Andrea
    Gonzalez-Iglesias, Eva
    Leeder, J. Steven
    Abad-Santos, Francisco
    Gaedigk, Andrea
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2023, 114 (05) : 1033 - 1042
  • [3] What is the Current Clinical Impact of the CYP2CTG Haplotype?
    Ingelman-Sundberg, Magnus
    Jukic, Marin
    Braten, Line Skute
    Kringen, Marianne Kristiansen
    Molden, Espen
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (02) : 183 - 183
  • [4] Impact of the novel CYP2C:TG haplotype and CYP2B6 variants on sertraline exposure in a large patient population
    Braten, Line Skute
    Ingelman-Sundberg, Magnus
    Jukic, Marin M.
    Molden, Espen
    Kringen, Marianne Kristiansen
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2022, 15 (09): : 2135 - 2145
  • [5] Distribution of a novel CYP2C haplotype in Native American populations
    Fernandes, Vanessa Camara
    Pretti, Marco Antonio M.
    Tsuneto, Luiza Tamie
    Petzl-Erler, Maria Luiza
    Suarez-Kurtz, Guilherme
    FRONTIERS IN GENETICS, 2023, 14
  • [6] Is CYP2C Haplotype Relevant for Efficacy and Bleeding Risk in Clopidogrel-Treated Patients?
    Ganoci, Lana
    Palic, Jozefina
    Trkulja, Vladimir
    Starcevic, Katarina
    Simicevic, Livija
    Bozina, Nada
    Lovric-Bencic, Martina
    Poljakovic, Zdravka
    Bozina, Tamara
    GENES, 2024, 15 (05)
  • [7] Clinical relevance of genetic polymorphisms in the human CYP2C subfamily
    Goldstein, JA
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2001, 52 (04) : 349 - 355
  • [8] CYP2C18: the orphan in the CYP2C family
    Zubiaur, Pablo
    Gaedigk, Andrea
    PHARMACOGENOMICS, 2022, 23 (16) : 913 - 916
  • [9] Ethnic differences in drug metabolism and response: The CYP2C polymorphisms - Impact of drug therapy in Asia
    Ishizaki, T
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1998, 358 (01) : R14 - R14
  • [10] Analyses of CYP2C in Porcine Microsomes
    Skaanild, Mette T.
    Friis, Christian
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2008, 103 (05) : 487 - 492
12345